+49 30 46307-200

Novozymes acquires Organobalance GmbH, 15 September 2016


Nature offers numerous opportunities to improve the well-being of humans, animals and the environment. Here at ORGANOBALANCE we have specialized in research and development around the natural diversity of microorganisms. We explore the vast potential of microorganisms for the development of highly innovative and natural compounds and products for the fields of food, feed, personal care, agriculture, the chemical and the pharmaceutical industry.

Furthermore, we contribute to the solution of future challenges of modern society through the development of efficient production microorganisms for the synthesis of valuable compounds. We use our scientific and technical expertise and ingenuity to design sustainable solutions.

ORGANOBALANCE works as service partner, in exclusive partnerships with companies from various industry segments, and out-licenses proprietary product developments.


31 January 2017
PROBIOTA 2017: Latest Findings in Bacteria Research
International science congress to take place in Berlin for the first time
- Press release

25 January 2017
Cold Virus Notwithstanding: Excessive Hand Washing Is Harmful
Mild skin products developed, supported by the Federal Ministry of Education and Research
- Press release

24 November 2016
Clinical Study Shows Bacteria Are Good For Your Skin
- Press release

10 November 2016
Successful Digestive Health Ingredient Pylopass™
Launches in the U.S. Market under the Life Extension Brand
- Press release

15 September 2016
Novozymes acquires Organobalance GmbH to
strengthen position in microbial solutions
- Press release



  • Gustav-Meyer-Allee 25, Geb.12, Etage 3
  • 13355 Berlin
  • Germany
  • info@organobalance.com
  • Tel.: +49 30 46307-200
  • Fax: +49 30 46307-210
  • www.organobalance.de